Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024

VERO 10.02.2024

Full Press ReleaseSEC FilingsOur VERO Tweets

About Gravity Analytica

Recent News

  • 11.13.2024 - Venus Concept Third Quarter of Fiscal Year 2024 Earnings Conference Call
  • 11.13.2024 - Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results
  • 11.07.2024 - Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India

Recent Filings

  • 01.10.2025 - DEF 14A Other definitive proxy statements
  • 01.07.2025 - 8-K Current report
  • 12.20.2024 - PRE 14A Other preliminary proxy statements

TORONTO,Oct. 02, 2024(GLOBE NEWSWIRE) --Venus Concept Inc.(“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2024 financial results will be released before the market opens onWednesday, November 13, 2024.

Management will host a conference call at8:00 a.m. Eastern TimeonNovember 13, 2024to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13749236. A live webcast of the call will also be provided on the investor relations section of the Company's website atir.venusconcept.com.

For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13749236. The webcast will be archived atir.venusconcept.com.

AboutVenus Concept

Venus Conceptis an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 12 direct markets.Venus Concept'sproduct portfolio consists of aesthetic device platforms, includingVenus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva,Venus Glow,Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME.Venus Concept'shair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system.Venus Concepthas been backed by leading healthcare industry growth equity investors includingEW Healthcare Partners(formerlyEssex Woodlands),HealthQuest Capital,Longitude Capital Management,Aperture Venture Partners, Masters Special Situations, andMadryn Asset Management, L.P.

Investor Relations Contact:ICR Westwicke on behalf of Venus ConceptMike Piccinino, CFAVenusConceptIR@westwicke.com

Primary Logo

Source: Venus Concept Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com